What are the active and inactive ingredients in Robitussin children's cough medicine?

Robitussin Children's Cough Medicine Ingredients

Based on FDA labeling, Robitussin children's formulations contain guaifenesin as the active ingredient, an expectorant designed to loosen and relieve chest congestion 1. However, it is critical to understand that over-the-counter cough medications should generally be avoided in children below 6 years of age due to lack of efficacy and potential for serious adverse events, including death 2, 3.

Active Ingredient

• Guaifenesin (syrup, USP): An expectorant that theoretically helps loosen mucus and phlegm in the airways 1

Key Safety Information

Age-Specific Restrictions

The FDA-approved labeling specifies 1:

• Children under 6 years: Do not use
• Children 6 to under 12 years: 1-2 teaspoonfuls every 4 hours
• Children 12 years and over (adult dose): 2-4 teaspoonfuls every 4 hours

Critical Safety Concerns

The evidence strongly argues against using OTC cough medications in young children:

• Between 1969-2006, there were 69 fatalities in children ≤6 years associated with antihistamines and 54 fatalities associated with decongestants found in OTC cough preparations 3
• Drug overdose and toxicity commonly resulted from using multiple cold/cough products simultaneously, medication errors, accidental exposures, and intentional overdose 3
• In 2007, major manufacturers (Wyeth, Novartis, Prestige Brands, Johnson & Johnson) voluntarily removed cough and cold medications for children under 2 years from the market 3

Evidence-Based Recommendations

The 2020 CHEST guidelines provide the most current, authoritative guidance 2:

1. OTC cough and cold medicines should NOT be prescribed to children until proven to make cough less severe or resolve sooner (which they have not been)
2. Preparations containing antihistamine and dextromethorphan are associated with adverse events
3. Little to no benefit exists for symptomatic control of acute or chronic cough in children

What Works Instead

• Honey (for children ≥1 year): Offers more relief than no treatment, diphenhydramine, or placebo 2
• Avoid codeine-containing medications due to potential for serious side effects including respiratory distress 2

Common Pitfalls to Avoid

• Do not assume "children's" labeling means safe for all children - age restrictions exist for good reason
• Do not combine multiple cough/cold products - this dramatically increases overdose risk 3
• Do not use increased doses when standard doses don't work - this increases toxicity without improving efficacy 4
• Do not treat cough symptomatically without identifying the underlying cause - cough should be treated based on etiology (asthma, infection, etc.) 2

Inactive Ingredients

While the FDA label 1 indicates this is an "alcohol-free cough formula," specific inactive ingredients are not detailed in the provided evidence. The formulation is a syrup preparation designed for oral administration.

Bottom line: While Robitussin children's products contain guaifenesin as the active ingredient, the overwhelming evidence demonstrates these medications lack proven efficacy in children and carry significant safety risks, particularly in those under 6 years of age 2, 3, 2.